Cardiovascular research continues to be a major focus at Saint Luke’s Health System. The program currently encompasses research programs in each of the major clinical areas, including interventional cardiology, cardiac surgery, heart failure and cardiac transplantation, cardiac electrophysiology, cardiac imaging, and preventive cardiology/lipid and diabetes management.
These programs enroll hundreds of patients annually in a broad range of randomized trials and registry-based research studies and are essential to the mission of Saint Luke’s Mid America Heart Institute (MAHI). Research allows MAHI to remain on the leading edge of cardiovascular care. In addition to these clinical research programs, many MAHI cardiologists participate in research through the Ben D. McCallister Clinical Scholars Program, which provides funding and support for investigator-initiated studies.
In addition to supporting clinical research, the cardiovascular research program encompasses centers of excellence and core laboratories in cardiovascular outcomes research, health economics and technology assessment, intravascular imaging, and noninvasive imaging. These centers of excellence currently serve as core laboratories for a wide range of studies that often involve collaboration with other leading cardiovascular centers and researchers from around the world. MAHI continues to serve as one of the four Analytic Centers, along with Duke, Harvard, and Yale, for the American College of Cardiology’s National Cardiovascular Data Registry.
Celebrating Three Decades of Cardiac Transplant
Research involving the surgical treatment of heart failure with cardiac transplantation continues to grow under the leadership of Michael Borkon, M.D., chairman of the Department of Cardiovascular and Thoracic Surgery and director of cardiac transplantation.
In 2015, Saint Luke’s celebrated 30 years of its successful heart transplant program. Nearly 700 cardiac transplants have been performed at Saint Luke’s Mid America Heart Institute since 1985. The transplant database serves as a rich source for clinical research and an important mechanism to validate clinical practice. Dr. Borkon’s research on the importance of performing a tricuspid annuloplasty on the donor heart at the time of cardiac transplantation entitled “Tricuspid Annuloplasty Definitely Improves Patient Outcomes in the First Year After Heart Transplantation” will be presented at the 2016 International Society of Heart and Lung Transplantation.